1.Determinants of late-stage HIV disease at diagnosis in Singapore, 1996 to 2009.
Jeannie S H TEY ; Li Wei ANG ; Joanne TAY ; Jeffery L CUTTER ; Lyn JAMES ; Suok Kai CHEW ; Kee Tai GOH
Annals of the Academy of Medicine, Singapore 2012;41(5):194-199
INTRODUCTIONThe delay in HIV diagnosis has been identified as a significant reason for late presentation to medical care. This research aims to elucidate the significant determinants of late-stage HIV infection in Singapore between 1996 and 2009, after the advent of highly active anti-retroviral therapies.
MATERIALS AND METHODSWe included 3735 patients infected via sexual mode of transmission from the National HIV Registry diagnosed between 1996 and 2009. Late-stage HIV infection is defined as CD4 count less than 200 mm(3) or AIDS-defining opportunistic infections at fi rst diagnosis or within one year of HIV diagnosis. We determined independent epidemiological risk factors for late-stage HIV infection at first diagnosis using multivariate logistic regression.
RESULTSMultivariate analysis showed that older age corresponded significantly with increasing odds of late-stage HIV infection. Compared to persons diagnosed at 15 to 24 years of age, those diagnosed at age 55 years and above were associated with 5-fold increased likelihood of late-stage infection (adjusted odds ratio (AOR): 5.17; 95% CI, 3.21 to 8.33). Chinese ethnicity, singlehood, and non-professional occupations were also significantly associated with late-stage HIV infection. Persons detected in the course of medical care had over 3.5 times the odds of late-stage infection (AOR: 3.55; 95% CI, 2.71 to 4.65). Heterosexual mode of transmission and having sex workers and social escorts as sexual partners, were the other epidemiological risk factors with significant associations.
CONCLUSIONThe findings of this study emphasises the need to increase HIV awareness and to encourage early and regular HIV testing among at-risk persons.
Adolescent ; Adult ; Age Factors ; Delayed Diagnosis ; statistics & numerical data ; Disease Notification ; Female ; HIV ; HIV Infections ; diagnosis ; epidemiology ; Humans ; Logistic Models ; Male ; Middle Aged ; Registries ; Retrospective Studies ; Risk Factors ; Sex Workers ; statistics & numerical data ; Sexual Behavior ; statistics & numerical data ; Singapore ; epidemiology
2.Ministry of Health Clinical Practice Guidelines: Lipids.
E Shyong TAI ; Boon Lock CHIA ; Amber Carla BASTIAN ; Terrance CHUA ; Sally Chih Wei HO ; Teck Siew KOH ; Lip Ping LOW ; Jeannie S TEY ; Kian Keong POH ; Chee Eng TAN ; Peter TING ; Tat Yean THAM ; Sue-Anne TOH ; Rob M van DAM
Singapore medical journal 2017;58(3):155-166
The Ministry of Health (MOH) has updated the Clinical Practice Guidelines on Lipids to provide doctors and patients in Singapore with evidence-based treatment for lipids. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH Clinical Practice Guidelines on Lipids, for the information of SMJ readers. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: http://www.moh.gov.sg/content/moh_web/healthprofessionalsportal/doctors/guidelines/cpg_medical.html.
Adult
;
Cardiovascular Diseases
;
complications
;
therapy
;
Child
;
Coronary Artery Disease
;
complications
;
therapy
;
Decision Support Systems, Clinical
;
Dyslipidemias
;
blood
;
complications
;
therapy
;
Evidence-Based Medicine
;
Female
;
Humans
;
Kidney Failure, Chronic
;
complications
;
therapy
;
Life Style
;
Lipids
;
blood
;
Lipoproteins, LDL
;
blood
;
Male
;
Practice Guidelines as Topic
;
Pregnancy
;
Pregnancy Complications
;
Risk Assessment
;
Risk Factors
;
Singapore
3.Assessment of the risk posed to Singapore by the emergence of artemisinin-resistant malaria in the Greater Mekong Subregion
Emma Xuxiao Zhang ; Jean-Marc Chavatte ; Cherie See Xin Yi ; Charlene Tow ; Wong Jia Ying ; Kamran Khan ; Olivia Seen Huey Oh ; Sarah Ngeet Mei Chin ; Khong Wei Xin ; Zubaidah Said ; Lyn James ; Jeffery Cutter ; Marc Ho ; Jeannie Su Hui Tey
Western Pacific Surveillance and Response 2019;10(2):6-13
Objective:
To assess the public health risk to Singapore posed by the emergence of artemisinin-resistant (ART-R) malaria in the Greater Mekong Subregion (GMS).
Methods:
We assessed the likelihood of importation of drug-resistant malaria into Singapore and the impact on public health of its subsequent secondary spread in Singapore. Literature on the epidemiology and contextual factors associated with ART-R malaria was reviewed. The epidemiology of malaria cases in Singapore was analysed. The vulnerability and receptivity of Singapore were examined, including the connectivity with countries reporting ART-R malaria, as well as the preparedness of Singaporean health authorities. Sources of information include international journals, World Health Organization guidelines, data from the Singapore Ministry of Health and National Public Health Laboratory of the National Centre for Infectious Diseases, and the International Air Transport Association.
Results:
The importation of ART-R malaria into Singapore is possible given the close proximity and significant travel volume between Singapore and the GMS countries reporting artemisinin resistance. Singapore’s vulnerability is further enhanced by the presence of foreign workers from neighbouring endemic countries. Nonetheless, the overall likelihood of such an event is low based on the rarity and decreasing trend of imported malaria incidence.
With the presence of Anopheles vectors in Singapore, imported cases of drug-resistant malaria could cause secondary transmission. Nevertheless, the risk of sustained spread is likely to be mitigated by the comprehensive surveillance and control system in place for both infected vectors and human cases.
Discussion
This risk assessment highlights the need for a continued high degree of vigilance of ART-R malaria locally and globally to minimize the risk and public health impact of drug-resistant malaria in Singapore.
4.Ministry of Health Clinical Practice Guidelines: Hypertension.
Jam Chin TAY ; Ashish Anil SULE ; E K CHEW ; Jeannie S TEY ; Titus LAU ; Simon LEE ; Sze Haur LEE ; Choon Kit LEONG ; Soo Teik LIM ; Lip Ping LOW ; Vernon Min Sen OH ; K Y PHOON ; Kian Wee Kenneth TAN ; Akira WU ; Loo See YEO
Singapore medical journal 2018;59(1):17-27
The Ministry of Health (MOH) has updated the clinical practice guidelines on hypertension to provide doctors and patients in Singapore with evidence-based treatment for hypertension. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH clinical practice guidelines on hypertension, for the information of SMJ readers. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: http://www.moh.gov.sg/content/moh_web/healthprofessionalsportal/doctors/guidelines/cpg_medical.html. The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.
Antihypertensive Agents
;
therapeutic use
;
Blood Pressure
;
Evidence-Based Medicine
;
Health Promotion
;
Humans
;
Hypertension
;
diagnosis
;
therapy
;
Life Style
;
Risk Factors
;
Singapore